As shown in Fig. 10, high expression of CCR7, IL2RG, CXCL9 and MAPK10 was associated with elevated drug sensitivity of cancer cells, while high expression of FLT3 was associated with diminished drug sensitivity of cancer cells to one drug (INK-128). The gene discussed is FLT3; the disease is cancer.